Proton pump inhibitor therapy and potential long-term harm.

Area of Science:

• Pharmacology
• Gastroenterology
• Internal Medicine

Background:

• Proton pump inhibitors (PPIs) are widely prescribed for acid-related gastrointestinal disorders.
• Their extensive use, driven by perceived safety and efficacy, often leads to overuse, inappropriate dosing, or prolonged treatment durations.
• Understanding potential side effects and drug interactions is crucial for optimizing patient care.

Purpose of the Study:

• To review the current literature on the potential adverse effects associated with proton pump inhibitor (PPI) therapy.
• To identify known interactions between PPIs and the metabolism or absorption of other medications.
• To provide an evidence-based summary for clinicians regarding PPI safety and risks.

Main Methods:

• Systematic review of recent scientific literature.
• Analysis of clinical studies and case reports on PPI side effects.
• Examination of pharmacological data on drug metabolism and absorption interactions.

Main Results:

• PPIs are generally well-tolerated, but overuse is common.
• Potential risks include hypomagnesemia and a possible link to microscopic colitis.
• Associations with infections (e.g., C. difficile) and bone integrity issues remain controversial.
• Long-term use may complicate existing health conditions through various mechanisms, including hypochlorhydria.

Conclusions:

• Short-term, standard-dose PPI treatment carries a low risk of adverse events.
• Long-term PPI therapy necessitates careful patient selection and monitoring due to potential complications.
• Further research is needed to fully elucidate the long-term effects and interactions of PPIs.